Sam Brusco, Associate Editor05.17.24
Philips has announced retrospective study results demonstrating the benefits of its AI-powered cardiac care solutions, which will be presented at this year’s Heart Rhythm Annual Meeting.
Findings from three studies highlighted how cardiac monitoring technology supports early detection of adverse cardiac events. The results also showed how it enables life-saving interventions as well as reduce readmissions and lower costs.
One study compares the outcomes of using Philips’ mobile cardiac output telemetry (MCOT) wearable ECG sensor with implantable loop recorders (ILRs) in stroke patients to determine how cardiac remote monitoring tech affects current standards of care.
After 18 months following a stroke event using MCOT vs. ILR, patients were found to have much lower readmissions—30.2% in the MCOT group compared to 35.4% in the ILR group. MCOT also reduced average cost over an 18-month period after the stroke even by $27,429.
Philips also reported lower utilization of the emergency department, and that patients with complications and comorbidities from the index stroke had a higher survival rate.
“As we explore how specific ambulatory monitoring devices, like MCOT, impact clinical outcomes, data demonstrates that choice of monitoring modality does affect the cost-effectiveness of care and patient outcomes,” said Manish Wadhwa, chief medical officer for Philips Ambulatory Monitoring & Diagnostics. “Effective cardiac monitoring starts with quality data, and with the AI-powered data platform behind MCOT, Philips is uniquely positioned to help care teams make quick, impactful, and cost-conscious decisions for their cardiac patients.”
Findings from three studies highlighted how cardiac monitoring technology supports early detection of adverse cardiac events. The results also showed how it enables life-saving interventions as well as reduce readmissions and lower costs.
One study compares the outcomes of using Philips’ mobile cardiac output telemetry (MCOT) wearable ECG sensor with implantable loop recorders (ILRs) in stroke patients to determine how cardiac remote monitoring tech affects current standards of care.
After 18 months following a stroke event using MCOT vs. ILR, patients were found to have much lower readmissions—30.2% in the MCOT group compared to 35.4% in the ILR group. MCOT also reduced average cost over an 18-month period after the stroke even by $27,429.
Philips also reported lower utilization of the emergency department, and that patients with complications and comorbidities from the index stroke had a higher survival rate.
“As we explore how specific ambulatory monitoring devices, like MCOT, impact clinical outcomes, data demonstrates that choice of monitoring modality does affect the cost-effectiveness of care and patient outcomes,” said Manish Wadhwa, chief medical officer for Philips Ambulatory Monitoring & Diagnostics. “Effective cardiac monitoring starts with quality data, and with the AI-powered data platform behind MCOT, Philips is uniquely positioned to help care teams make quick, impactful, and cost-conscious decisions for their cardiac patients.”